Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,098.00
Bid: 12,098.00
Ask: 12,100.00
Change: 70.00 (0.58%)
Spread: 2.00 (0.017%)
Open: 12,036.00
High: 12,104.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sterling holds firm as vaccine jitters ebb

Wed, 17th Mar 2021 09:33

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv

By Ritvik Carvalho

LONDON, March 17 (Reuters) - Sterling held firm against both
the euro and the dollar as Britain's dismissal of safety
concerns over the AstraZeneca vaccine gave the currency some
berth to recovery from the previous day's falls.

A number of European countries, including Germany, France
and Italy, have suspended AstraZeneca shots following reports of
blood coagulation disorders in some recipients. Their safety
concerns prompted a selloff in the pound on Tuesday as Britain
is continuing to administer the vaccine.

Sterling then recovered some of those losses on Tuesday
after Europe's medical watchdog, echoing other health bodies,
reiterated its view that there was no evidence that the vaccine
was unsafe.

By 0900 GMT on Wednesday, sterling was flat against the
dollar at $1.3898 and 0.1% higher to the euro at 85.60
pence, not far off a year's high of 85.40 pence per
euro.

"UK authorities have dismissed safety concerns on the
AstraZeneca vaccine, which should leave the pound less
vulnerable than other European currencies to the suspension
story," said strategist at ING in a note to clients.

"A wait-and-see approach may prevail in GBP price action as
we head to the Bank of England meeting tomorrow."

Hopes that Britain's rapid vaccine rollout will lead to a
faster reopening of its economy and a rebound from its worst
annual contraction in output in 300 years have benefited
sterling this year, with the pound until recently the best
performing G10 currency.

However, as a spike in U.S. bond yields lifted the dollar
over the past few weeks, sterling has come well off the $1.4240
- its highest levels against the dollar in nearly 3 years which
it hit on Feb. 24.

Besides optimism about a vaccine-enabled economic recovery,
relief over a Brexit trade deal and the Bank of England's
pushing out of expectations of negative interest rates have also
helped sterling. The BoE meets on Thursday.

Bank of England Governor Andrew Bailey said on Monday he was
more optimistic about the economy, though "with a large dose of
caution", and a recent rise in interest rates in financial
markets was consistent with the prospects of recovery from the
COVID slump.

Rabobank said in a research note that the pace of any gains
for the pound "will be far slower than in the year to date."

"We retain our medium-term forecast of EUR/GBP 0.85 but see
scope for pullbacks to the 0.86-0.87 area in Q2."
(Reporting by Ritvik Carvalho;
Editing by Gareth Jones)

More News
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.